Prospective study of risk factors for ventilator-associated pneumonia caused by Acinetobacter species

Journal of Critical Care

Volumn 22, Issue 1, 2007, Pages 18-26

  Medina, Julio ^a   Formento, Carlos ^b   Pontet, Julio ^b,c   Curbelo, Andrea ^d   Bazet, Cristina ^b,e   Gerez, Jorge ^d   Larrañaga, Eduardo ^d  

^a Universidad de la Republica Instituto de Higiene   (Uruguay)

^b Hospital Pasteur Montevideo   (Uruguay)

^c DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^d Hospital Policial   (Uruguay)

^e HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

Acinetobacter spp; Antibiotics; Intensive care unit; Prospective cohort study; Specific risk factors; Ventilator associated pneumonia

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; CARBAPENEM; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; METRONIDAZOLE; PENICILLIN G; SULPERAZON; SULTAMICILLIN; VANCOMYCIN;

ACINETOBACTER; ADULT; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PREDICTOR VARIABLE; PROSPECTIVE STUDY; RISK FACTOR; UNIVARIATE ANALYSIS; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CIPROFLOXACIN; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33947222485     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2006.06.010     Document Type: Article

References (38)

1. Baraibar J., Correa H., Mariscal D., et al. Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest 112 (1997) 1050-1054
2. Akca O., Koltka K., Usel S., et al. Risk factors for early-onset, ventilator-associated pneumonia in critical care patients: selected multiresistant versus nonresistant bacteria. Anesthesiology 93 3 (2000) 638-645
3. Husni R., Goldstein L., Arroliga A., et al. Risk factors for an outbreak of multi-drug-resistant acinetobacter nosocomial pneumonia among intubated patients. Chest 115 (1999) 1378-1382
4. Lortholary O., Fagon J.Y., Hoi A.B., et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 20 4 (1995) 790-796
5. Garnacho J., Sole-Violan J., Sa-Borges M., et al. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med 31 10 (2003) 2478-2482
6. Fagon J.Y., Chastre J., Hance A.J., et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 94 3 (1993) 281-288
7. Koprnova J., Svetlansky I., Babel'a R., et al. Prospective study of antibacterial susceptibility, risk factors and outcome of 157 episodes of Acinetobacter baumannii bacteremia in 1999 in Slovakia. Scand J Infect Dis 33 12 (2001) 891-895
8. Kollef M.H., and Fraser V.J. Antibiotic resistance in the intensive care unit. Ann Intern Med 134 4 (2001) 298-314
9. Landman D., Quale J.M., Mayorga D., et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med 162 13 (2002) 1515-1520
10. Bergogne-Bérézin E., and Townern K.J. Acinetobacter spp. As nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9 (1996) 148-165
11. Arnow P., and Flaherty J.P. Nonfermentative gram-negative bacilli. In: Mayhall C.G. (Ed). Hospital epidemiology and infection control. 2nd ed. (1999), Lippincott Williams & Wilkins, Philadelphia 431-451
12. Fagon J.Y., Chastre J., Domart Y., et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 139 (1989) 877-884
13. Villers D., Espaze E., Coste-Burel M., et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 129 (1998) 182-189
14. Johanson W.G., Pierce A., Sanford J., et al. Nosocomial respiratory infections with gram negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 77 (1972) 701-706
15. Pingleton S.K., Fagon J.Y., and Leeper Jr. K.V. Patient selection for clinical investigation of ventilator-associated pneumonia: criteria for evaluating diagnostic techniques. Chest 102 (1992) 553S-556S
16. Ibrahim E.H., Ward S., Sherman G., Schaiff R., Fraser V.J., and Kollef M.H. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 29 (2001) 1109-1115
17. Flanagan P., Findlay G., Magee J., et al. The diagnosis of ventilator-associated pneumonia using non-bronchoscopic, non-directed lung lavages. Intensive Care Med 26 (2000) 20-30
18. Montravers P., Fagon J.Y., Chastre J., Lecso M., Dombret M.C., Trouillet J.L., et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 147 1 (1993) 38-44
19. Bergmans D., Bonten M., Leeuw P., et al. Reproducibility of quantitative cultures of endotracheal aspirates from mechanically ventilated patients. J Clin Microbiol 35 (1997) 796-798
20. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 3 Pt 1 (1994) 818-824
21. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovates therapies in sepsis. The ACCP (An American College of Chest Physician), SCCM (Society of Critical Care Medicine) Consensus conference committee. Chest 101 (1992) 1644-1655
22. Ewig S., Ruiz M., Mensa J., et al. Severe community-acquired pneumonia: assessment of severity criteria. Am J Respir Crit Care Med 158 (1998) 1102-1108
23. Dennesen P., van der Ven A., Kessels A., Ramsay G., and Bonten M. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 163 (2001) 1371-1375
24. Schreckenberger P.C., and Von Graevenitz. Acinetobacter, achomobacter, Alcaligenes, Moraxella, methylobacterium, and other nonfermentative gram negative rods. In: En Murray P., Baron E., Pfaller M., Tenover F., and Molken R. (Eds). Manual of clinical microbiology. 7th ed. (1999), American Society of Microbiology, Washington (DC) 539-560
25. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Eleventh informational Supplement NCCLS M 100 S 11 Wayne, Pa, 2001.
26. Zwillich C., Pierson D., Creagh E., et al. Complications of assisted ventilation. A prospective Study of 354 consecutive Episodes. Am J Med 57 (1974) 161-170
27. McCabe W., and Jackson G. Gram-negative bacteriemia. Arch Intern Med 110 (1962) 847-864
28. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-819
29. Marshall J.C., Cook D.J., Christou N.V., et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23 (1995) 1638-1652
30. Vincent J.L., Moreno R., Takala J., et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 22 (1996) 707-710
31. Mamdani M., Sykora K., Li P., Normand S., Streiner D., Austin P., et al. Reader's guide to critical appraisal of cohort studies: assessing potential for confounding. BMJ 330 (2005) 960-962
32. Costa S.F., Newbaer M., Santos C.R., Basso M., Soares I., and Levin A.S. Nosocomial pneumonía: importante of recognition of etiologic agents to define an aprópiate inicial empirical therapy. Int J Antimicrob Agents 17 2 (2001) 147-150
33. Santucci S.G., Gobara S., Santos C.R., Fontana C., and Levin A.S. Infections in burn intensive care unit: experience of seven years. J Hosp Infect 53 1 (2003) 6-13
34. Trouillet J.-L., Chastre J., Vuagnat A., Joly-Guillou M.-L., Combaux D., Dombret M.-C., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157 (1998) 531-539
35. Chastre J. Infections due to Acinetobacter baumannii in the ICU. Semin Respir Crit Care Med 24 (2003) 69-77
36. Gruson D., Hilbert G., Vargas F., et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Am J Respir Crit Care Med 162 (2000) 837-843
37. Raymond D., Pelletier S., Crabtree T., et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 29 (2001) 1101-1108
38. PetriJr W. Antimicrobial agents: penicillins, cephalosporins, and other β-lactam antibiotics. In: Hardman J.G., Limbird L.E., and Gilman A.G. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. (2001), McGraw-Hill, New York 1171-1188